Wednesday, February 23, 2022

GODREJCP

GODREJCP(Godrej Consumer Products Limited)

09.11.2022 - MS on Godrejcp Maintain Overweight CMP 810.85 Target 1101
06.10.2022 - CITI on Godrejcp Maintain Buy CMP 855.1 Target 1050
29.09.2022 - MS on Godrejcp Maintain Overweight CMP 909.4 Target 1101
29.09.2022 - CS on Godrejcp Maintain Outperform CMP 909.4 Target 975
29.09.2022 - Jefferies on Godrejcp Maintain Buy CMP 909.4 Target 1040
05.08.2022 - MS on Godrejcp Maintain Underweight CMP 853.45 Target 700
07.07.2022 - CLSA on Godrejcp Maintain Outperform CMP 854.4 Target 890
20.05.2022 - MS on Godrejcp Maintain Underperform CMP 756 Target 700
20.05.2022 - Nomura on Godrejcp Maintain Buy CMP 756 Target 950
15.02.2022 - MS on GodrejCons Maintain Underweight CMP 799 Target 829
21.12.2021 - UBS On Godrej Cons- Maintain Buy CMP 891 - Target Rs.1175
21.12.2021 - Morgan Stanley On Godrej Cons- Maintain Underweight CMP 891 - Target Rs.829

CLSA ON GODREJ CONS : 05.08.2021

* CLSA maintains OUTPERFORM call on Godrej Cons, target at Rs 950/sh
* Margin Pressure In India Offset By Better Margin Show In International
* Earnings Growth Of 38% Aided By Higher-than-expected Other Income
* Gross Debt Expanded By *300 Cr Against Guidance Of A Reduction
* Working Capital Days Expanded To 23 Days
* MAINTAIN OUTPERFORM TARGET: 950

MOTILAL OSWAL ON GODREJ CONSUMER : 09.06.2021

• Maintain BUY, Target at Rs 1,020/share
• Pieces of the growth puzzle coming together
• Markets pricing in revitalization of both earnings & ROCE over the next few years
* Other pieces of the growth puzzle are also coming together
* Delving into the factors behind the underperformance

ERIS

ERIS(Eris Lifesciences Ltd) 18.01.2023 -  Macquarie  on  ERIS Maintain Outperform CMP 625.75 Target 830